Alerts will be sent to your verified email
Verify Email
BROOKS
|
Brooks Laboratories
|
Alpa Lab
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.0 | 10.02 % | 28.02 % |
|
5yr average Equity Multiplier
|
1.68 | 1.26 | 1.4 |
|
5yr Average Asset Turnover Ratio
|
0.62 | 0.62 | 1.43 |
|
5yr Avg Net Profit Margin
|
-21.45 % | 13.26 % | 11.03 % |
|
Price to Book
|
1.27 | 0.79 | 0.63 |
|
P/E
|
6.79 | 12.47 | 15.83 |
|
5yr Avg Cash Conversion Cycle
|
23.75 Days | 114.37 Days | 154.28 Days |
|
Inventory Days
|
83.11 Days | 51.33 Days | 87.41 Days |
|
Days Receivable
|
80.26 Days | 142.78 Days | 103.86 Days |
|
Days Payable
|
163.46 Days | 94.49 Days | 63.18 Days |
|
5yr Average Interest Coverage Ratio
|
-11.18 | 94.43 | 57.05 |
|
5yr Avg ROCE
|
-11.18 % | 13.16 % | 36.52 % |
|
5yr Avg Operating Profit Margin
|
-10.26 % | 7.55 % | 16.64 % |
|
5 yr average Debt to Equity
|
0.18 | 0.02 | 0.09 |
|
5yr CAGR Net Profit
|
-12.45 % | 21.88 % | -5.76 % |
|
5yr Average Return on Assets
|
-13.31 % | 7.94 % | 18.47 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.62 % | 57.19 % | 65.99 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-13.79 % | -0.1 % | -5.58 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
9.9 % | 0.0 | 0.0 |
|
Brooks Laboratories
|
Alpa Lab
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|